Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Cerebral Small Vessel Disease | Research

Excessive salt intake accelerates the progression of cerebral small vessel disease in older adults

Authors: Di Liu, Qin Zhang, Shasha Xing, Fang Wei, Ke Li, Yingxin Zhao, Hua Zhang, Gary Gong, Yuqi Guo, Zhendong Liu

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

It is unclear whether excessive salt intake accelerates the progression of cerebral small vessel disease (CSVD). The major objective of this study was to investigate the harmful effect of excessive salt intake on the progression of CSVD in older individuals.

Methods

Between May 2007 and November 2010, 423 community-dwelling individuals aged 60 years and older were recruited from the Shandong area, China. Salt intake was estimated using 24-hour urine collection for 7 consecutive days at baseline. Participants were classified into low, mild, moderate and high groups according to the salt intake estimation. CSVD including white matter hyperintensities (WMHs), lacunes, microbleeds and an enlarged perivascular space (EPVS) were determined using brain magnetic resonance imaging.

Results

During an average of five years of follow-up, the WMH volume and WMH-to-intracranial ratio were increased in the four groups. However, the increasing trends in the WMH volume and WMH-to-intracranial ratio were significantly faster in the higher salt intake groups compared with the lower salt intake groups (Padjusted < 0.001). The cumulative hazard ratios of new-incident WMHs (defined as those with Fazekas scale scores ≥ 2), new-incident lacunes, microbleeds or an EPVS, as well as composites of CSVD, were respectively 2.47, 2.50, 3.33, 2.70 and 2.89 for the mild group; 3.72, 3.74, 4.66, 4.01 and 4.49 for the moderate group; and 7.39, 5.82, 7.00, 6.40 and 6.61 for the high group, compared with the low group after adjustment for confounders (Padjusted < 0.001). The risk of new-incident WMHs, lacunes, microbleeds or an EPVS, and composites of CSVD was significantly increased with each 1-standard-deviation increment in salt intake (Padjusted < 0.001).

Conclusion

Our data indicates that excessive salt intake is an important and independent contributor to the progression of CVSD in older adults.
Literature
16.
go back to reference Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, et al. The international consortium for quality research on dietary sodium/salt (TRUE) position statement on the use of 24-hour, spot, and short duration (< 24 hours) timed urine collections to assess dietary sodium intake. J Clin Hypertens (Greenwich). 2019;21(6):700–9. https://doi.org/10.1111/jch.13551.CrossRefPubMed Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, et al. The international consortium for quality research on dietary sodium/salt (TRUE) position statement on the use of 24-hour, spot, and short duration (< 24 hours) timed urine collections to assess dietary sodium intake. J Clin Hypertens (Greenwich). 2019;21(6):700–9. https://​doi.​org/​10.​1111/​jch.​13551.CrossRefPubMed
31.
go back to reference Szadkowski D, Jörgensen A, Essing HG, Schaller KH. Creatinine elimination rate as reference value for analysis of urine samples. I. Effect of daily urine volume and circadian rhythm on creatinine excretion. Z Klin Chem Klin Biochem. 1970;8(5):529–33.PubMed Szadkowski D, Jörgensen A, Essing HG, Schaller KH. Creatinine elimination rate as reference value for analysis of urine samples. I. Effect of daily urine volume and circadian rhythm on creatinine excretion. Z Klin Chem Klin Biochem. 1970;8(5):529–33.PubMed
Metadata
Title
Excessive salt intake accelerates the progression of cerebral small vessel disease in older adults
Authors
Di Liu
Qin Zhang
Shasha Xing
Fang Wei
Ke Li
Yingxin Zhao
Hua Zhang
Gary Gong
Yuqi Guo
Zhendong Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-03877-3

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine